s
Lyfegen Secures additional CHF 5 Million in Series A Funding to Scale Its Drug Rebate Management Platform Globally
11-12-2024, 12:23
BASEL, Switzerland and BOSTON, Dec. 11, 2024 /PRNewswire/ — Lyfegen, a global leader in drug rebate management technology, today announced the successful close of its additional CHF 5 million Series A funding round. The round was led by TX Ventures, a leading European fintech investor, with additional participation from aMoon, a global health-tech venture capital […] L'articolo Lyfegen Secures additional CHF 5 Million in Series A Funding to Scale Its Drug Rebate Management Platform Globally proviene da La Ragione.
CONTINUA A LEGGERE
24
0
0
Guarda anche
La Ragione
Ieri, 23:43
Referendum, Conte “Quorum dipende dai cittadini”
La Ragione
Ieri, 21:43
Alleanza per l’Equità nella Salute: coesione per il futuro del Paese
La Ragione
Ieri, 20:44
**2 giugno: Grigolo, ‘spero prevalga buon senso e Coro Fenice canti l’Inno’**
La Ragione
Ieri, 20:43
Referendum, Gualtieri “Lavoro precario piaga del nostro Paese”
La Ragione
Ieri, 19:43